Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 81, 105-110
Abstract
No abstract availableKeywords
Funding Information
- Suzhou Science and Technology Development (201578)
This publication has 49 references indexed in Scilit:
- The size and burden of mental disorders and other disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Elevated Cortisol in Older Adults With Generalized Anxiety Disorder Is Reduced by Treatment: A Placebo-Controlled Evaluation of EscitalopramThe American Journal of Geriatric Psychiatry, 2011
- Citalopram reduces endotoxin-induced fatigueBrain, Behavior, and Immunity, 2011
- Neural aspects of immunomodulation: Focus on the vagus nerveBrain, Behavior, and Immunity, 2010
- Risk Factors for Development of Depression and PsychosisAnnals of the New York Academy of Sciences, 2009
- Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interfaceBrain, Behavior, and Immunity, 2009
- Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behaviorMolecular Psychiatry, 2008
- IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stressProceedings of the National Academy of Sciences, 2008
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005